Testosterone's effects on body and face: what TikTok gets wrong

What's this video probably claiming?

A TikTok account called @testosterone.guru, sitting at 330K views, is almost certainly walking viewers through a visual tour of what testosterone does to the male body and face. The hashtags tell the story: #looksmaxing, #testosteronebooster, #trt. This is the classic convergence of legitimate hormone education and optimization-culture hype. Expect claims about jaw structure, skin oiliness, muscle hypertrophy, libido, and the kind of before-and-after framing that implies TRT is a cosmetic upgrade. The #testosteronebooster tag is particularly telling. That phrase almost always blurs the line between endogenous testosterone optimization and exogenous TRT, often without disclosing the clinical threshold for actual hypogonadism. Creators in this space routinely conflate the physiological effects of correcting a true deficiency with the speculative benefits of pushing levels into the supraphysiologic range. Without the transcript, we can't confirm specifics, but the pattern across this content category is consistent enough to analyze the underlying claims on their merits.

What does the science actually show?

Testosterone does produce measurable physical changes, but the timeline and magnitude depend heavily on baseline levels and individual variation. In men with confirmed hypogonadism, defined clinically as total testosterone below 300 ng/dL per the American Urological Association, TRT produces well-documented improvements in lean body mass, bone density, and sexual function. Bhasin et al. (2010, New England Journal of Medicine) showed dose-dependent increases in muscle strength and size with testosterone administration, but this was in older men with low baseline levels. A separate meta-analysis by Corona et al. (2016, European Journal of Endocrinology) found modest improvements in body composition with TRT in hypogonadal men, with lean mass increases averaging around 1.6 kg over 12 months. The facial changes often referenced in looksmaxing content, things like jaw definition or skin texture shifts, have far weaker evidentiary support, particularly in adult men whose facial bones have already fused. Sebum production does increase with higher androgens, which is documented, but that's a skin change, not a structural one.

Where does the social media noise diverge from clinical reality?

The looksmaxing community treats testosterone like a sculptor's tool for adult faces. The biology doesn't support that framing. Facial bone remodeling under androgen influence is primarily a pubescent phenomenon. By the mid-20s, the morphological window has largely closed. What TRT actually changes in adults is body composition, red blood cell production, mood, and in some cases libido and cognitive function. The #testosteronebooster hashtag is a red flag for another reason: most supplements marketed under that label, think ashwagandha, D-aspartic acid, fenugreek, produce effects too small to be clinically meaningful in men with normal baseline testosterone. Sharma et al. (2013, Evidence-Based Complementary and Alternative Medicine) found ashwagandha improved testosterone levels modestly in infertile men, but extrapolating that to healthy men seeking physique changes is a significant stretch. The TikTok optimization framing also rarely discusses hematocrit elevation, testicular atrophy from endogenous suppression, or the cardiovascular data that remains genuinely contested.

What should you actually know?

If your testosterone is clinically low, TRT under physician supervision is a legitimate, regulated medical intervention with a real evidence base. That's not what most of this content is selling. The Endocrine Society's clinical practice guidelines (Bhasin et al., 2018, Journal of Clinical Endocrinology and Metabolism) recommend treatment for men with consistent symptoms of hypogonadism and unequivocally low testosterone on at least two morning measurements. The guidelines explicitly do not recommend TRT in men with age-related testosterone decline who are otherwise healthy, or for body composition goals in eugonadal men. Risks that rarely make the TikTok edit include polycythemia, suppression of spermatogenesis, potential cardiovascular effects still being studied in the TRAVERSE trial (Lincoff et al., 2023, New England Journal of Medicine), and acne. The TRAVERSE trial found no significant increase in major cardiovascular events compared to placebo in middle-aged hypogonadal men, which is reassuring, but that population is not the 22-year-old looker trying to optimize his jawline.